South San Francisco, CA, United States of America

Senti Biosciences, Inc.


USPTO Granted Patents = 5

% Expired Patents = 20.0

Trademarks = 6

Forward Citations = 7

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Russell Morrison Gordley (5 out of 7 patents)

silverMedal Brian Scott Garrison (4 out of 4 patents)

bronzeMedal Timothy Kuan-Ta Lu (3 out of 35 patents)

4.  Jack Tzu-Chiao Lin (3 out of 3 patents)

5.  Don-Hong Wang (3 out of 3 patents)

6.  Alba Gonzalez-Junca (3 out of 3 patents)

7.  Philip Janmin Lee (3 out of 29 patents)

8.  Daniel Frimannsson (2 out of 5 patents)

9.  Michelle Elizabeth Hung (2 out of 2 patents)

10.  Jennifer Chien (1 out of 1 patent)

11.  Kathryn Armstrong Loving (1 out of 1 patent)

12.  Gary Lee (1 out of 1 patent)


5 patents:

Company Overview
Senti Biosciences is a leading synthetic biology company developing programmable cell therapies for cancer treatment. Their platform combines synthetic biology, machine learning, and genome editing to engineer precision medicines that can target and eradicate cancer cells. The company's mission is to revolutionize the way cancer is treated by harnessing the power of biology and data to create personalized therapies for patients.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#151 in South San Francisco, CA

#12,058 in California

#51,570 in US

South San Francisco, CA (US)
South San Francisco, CA, United States of America
Forward Citations = 7

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Senti Biosciences, Inc.. Retrieved from https://idiyas.com/company/senti-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…